Regeneron
Regeneron has faced an unexpected rejection from the FDA for its high-dose version of Eylea due to manufacturing challenges
SG Tylor
Source – Regeneron Regeneron’s highly anticipated high-dose version of Eylea has suffered an unexpected setback as the FDA rejected its ...
